nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
|
15 |
6 |
p. 693-696 |
artikel |
2 |
A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
|
Louveau, Baptiste |
|
|
15 |
6 |
p. 759-771 |
artikel |
3 |
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
|
Fisher, Julie G. |
|
|
15 |
6 |
p. 733-741 |
artikel |
4 |
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
|
Faloppi, Luca |
|
|
15 |
6 |
p. 801-802 |
artikel |
5 |
Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3
|
Lüftner, Diana |
|
|
15 |
6 |
p. 805 |
artikel |
6 |
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
|
Niederwieser, Dietger |
|
|
15 |
6 |
p. 807 |
artikel |
7 |
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
|
Ramanathan, Ramesh K. |
|
|
15 |
6 |
p. 803 |
artikel |
8 |
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
|
Orsi, Giulia |
|
|
15 |
6 |
p. 809-810 |
artikel |
9 |
Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
|
Scott, Lesley J. |
|
|
15 |
6 |
p. 791-799 |
artikel |
10 |
Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis
|
Raphael, Jacques |
|
|
15 |
6 |
p. 723-732 |
artikel |
11 |
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
|
Sigorski, Dawid |
|
|
15 |
6 |
p. 709-722 |
artikel |
12 |
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
|
Orsi, Giulia |
|
|
15 |
6 |
p. 773-785 |
artikel |
13 |
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
|
Chong, Li Chia |
|
|
15 |
6 |
p. 751-757 |
artikel |
14 |
SB8: A Bevacizumab Biosimilar
|
Syed, Yahiya Y. |
|
|
15 |
6 |
p. 787-790 |
artikel |
15 |
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
|
Al Baghdadi, Tareq |
|
|
15 |
6 |
p. 743-750 |
artikel |
16 |
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
|
Theodoropoulos, Nicholas |
|
|
15 |
6 |
p. 697-708 |
artikel |